Sealed court documents show that a member of the Sackler family, which controls Stamford-based Purdue Pharma, agreed that the company should allow doctors to believe OxyContin was weaker than morphine.
David Armstrong | ProPublica
Posted inHealth
OxyContin maker explored expansion into anti-addiction
Not content with billions of dollars in profits from the potent painkiller OxyContin, its maker explored expanding into an “attractive market” fueled by the drug’s popularity — treatment of opioid addiction, according to previously secret passages in a court document filed by the state of Massachusetts.